The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug products, addressing the rising demand for reliable U.S.-based production. This investment comes as ...

LGM Pharma invests $6 mn in US drug manufacturing facility to increase capacity for liquid, suspension, semi-solid & suppository drug products: Boca Raton, Florida Saturday, March ...

Arbli is designed for patients who require or prefer an oral liquid formulation of losartan. According to Scienture, the oral suspension provides a convenient and safe option, removing the ...